1. Home
  2. COSM vs BEAT Comparison

COSM vs BEAT Comparison

Compare COSM & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cosmos Health Inc.

COSM

Cosmos Health Inc.

N/A

Current Price

$0.33

Market Cap

27.9M

Sector

Health Care

ML Signal

N/A

Logo Heartbeam Inc.

BEAT

Heartbeam Inc.

N/A

Current Price

$0.42

Market Cap

27.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
COSM
BEAT
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
27.7M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
COSM
BEAT
Price
$0.33
$0.42
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.63
AVG Volume (30 Days)
2.5M
305.7K
Earning Date
04-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
46.15
15.07
EPS
N/A
N/A
Revenue
$65,271,815.00
N/A
Revenue This Year
$54.08
N/A
Revenue Next Year
$32.66
$315.97
P/E Ratio
N/A
N/A
Revenue Growth
19.93
N/A
52 Week Low
$0.16
$0.39
52 Week High
$1.32
$4.00

Technical Indicators

Market Signals
Indicator
COSM
BEAT
Relative Strength Index (RSI) 72.77 37.35
Support Level $0.29 $0.39
Resistance Level $0.35 $0.52
Average True Range (ATR) 0.03 0.03
MACD 0.01 0.00
Stochastic Oscillator 93.37 24.19

Price Performance

Historical Comparison
COSM
BEAT

About COSM Cosmos Health Inc.

Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Share on Social Networks: